Table 2.
Neonatal and neurodevelopmental outcomes
| Perinatal anemia | Non-anemic | p value | |
|---|---|---|---|
| Neonatal outcome, n | 23 | 88 | |
| Outcome | |||
| Survival | 12 (52) | 69 (78) | 0.01 |
| Survival without disabilities | 12 (52) | 43 (49) | 0.82 |
| Redirection of care | 8 (73) | 16 (84) | 0.64 |
| Postnatal day redirection of care | 6 (3–9) | 6 (3–8) | 0.70 |
| Decision based only on aEEG and clinical condition | 5 (63) | 7 (44) | 0.67 |
| Neurodevelopmental outcome | |||
| BSID-III, n | 12 | 69 | |
| Normal | 12 (100) | 43 (62) | <0.01 |
| Abnormal | 0 (0) | 26 (38) | <0.01 |
| Cognitive composite score | 100±10 | 100±12 | 0.98 |
| Motor composite score | 104±11 | 95±15 | 0.02 |
| CBCL, n | 10 | 52 | |
| Normal | 8 (80) | 47 (90) | 0.61 |
| Subclinical | 1 (10) | 3 (6) | |
| Clinical | 1 (10) | 2 (4) | |
| Internalizing T-score | 43±7 | 44±10 | 0.53 |
| Externalizing T-score | 45±11 | 48±9 | 0.45 |
Data are presented as n (%), median (IQR) or as mean ± SD.
Hb, hemoglobin; aEEG, amplitude-integrated electroencephalography; BSID-III, Bayley Scales of Infant and Toddler Development (3rd edition); CBCL, child behavior checklist.